Your browser doesn't support javascript.
loading
A Case of Minimally Progressive Prodromal Alzheimer's Disease.
Rosenbloom, Michael H; Barclay, Terry.
  • Rosenbloom MH; HealthPartners Neuroscience Center/Research Institute, Saint Paul, MN, USA.
  • Barclay T; HealthPartners Neuroscience Center/Research Institute, Saint Paul, MN, USA.
J Alzheimers Dis Rep ; 7(1): 37-40, 2023.
Article en En | MEDLINE | ID: mdl-36777327
ABSTRACT
Prodromal Alzheimer's disease (AD) is a neurodegenerative condition typically progressing to dementia within 3 years. We describe a case of a mild cognitive impairment (MCI) patient with biomarker evidence for amyloidosis, tau, and neurodegeneration who had minimal changes in clinical phenotype during an 11-year period. AD biomarkers were obtained with cerebrospinal fluid analysis and amyloid PET imaging, both of which supported a biological diagnosis of AD. However, the patient's neuropsychological profile remained stable over 11 years except for mild memory-retrieval changes. This case provides evidence that MCI with supportive AD biomarkers may have an atypically minimal progression.
Palabras clave